Medical Condition News

RSS

Concerns raised about disproportionate impact of changes in hospital payment methods

Teaching hospitals with a higher intensity of physician-training activity achieve lower mortality rates, but higher hospitalization readmission rates for key medical diagnoses, reports a study in the July issue of Medical Care, published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

18 Jun 2013

New study identifies possible treatment to block deposition of calcium in arterial wall

HGPS is a rare genetic disease that affects one in every 4-8 million births. The disease is caused by a spontaneous mutation in one of the two copies (alleles) of the gene LMNA, which codes for lamin A, a protein important for the integrity and function of the envelope surrounding the cell nucleus. The mutation causes incorrect processing of the messenger RNA for lamin proteins, resulting in the synthesis of an anomalous protein, called progerin.

18 Jun 2013

HPV antibodies may help identify individuals at increased risk of HPV-related oropharynx cancer

Researchers have found that antibodies against the human papillomavirus (HPV) may help identify individuals who are at greatly increased risk of HPV-related cancer of the oropharynx, which is a portion of the throat that contains the tonsils.

18 Jun 2013

Drug increases amount of energy burned by fat tissue and promotes weight loss

A drug that mimics the activity of thyroid hormone significantly increases the amount of energy burned by fat tissue and promotes weight loss, an animal study of metabolism finds. The results were presented Sunday at The Endocrine Society's 95th Annual Meeting in San Francisco.

18 Jun 2013

Increasing red meat intake boosts risk of type-2 diabetes mellitus

Eating more red meat over time is associated with an increased risk of type-2 diabetes mellitus (T2DM) in a follow-up of three studies of about 149,000 U.S. men and women, according to a report published Online First by JAMA Internal Medicine, a JAMA Network publication.

18 Jun 2013

Study shows clear correlation between infection levels and risk of developing mood disorders

New research shows that every third person who is diagnosed for the first time with a mood disorder has been admitted to hospital with an infection prior to the diagnosis.

18 Jun 2013

Mannitol could prevent aggregation of toxic proteins in the brain, says Tel Aviv University researcher

Mannitol, a sugar alcohol produced by fungi, bacteria, and algae, is a common component of sugar-free gum and candy. The sweetener is also used in the medical field - it's approved by the FDA as a diuretic to flush out excess fluids and used during surgery as a substance that opens the blood/brain barrier to ease the passage of other drugs.

18 Jun 2013

Studies show fewer mental health inpatients experience delayed discharge from hospital

Two studies a decade apart in England show fewer mental health inpatients are experiencing delayed discharge from hospital, although finding accommodation on discharge is a greater problem.

17 Jun 2013

Study: Male mice fed with high-fat diet are more likely to father offspring with higher levels of body fat

Male mice who were fed a high-fat diet and became obese were more likely to father offspring who also had higher levels of body fat, a new Ohio University study finds.

17 Jun 2013

Bazedoxifene used for treating osteoporosis stops growth of breast cancer cells

A drug approved in Europe to treat osteoporosis has now been shown to stop the growth of breast cancer cells, even in cancers that have become resistant to current targeted therapies, according to a Duke Cancer Institute study.

17 Jun 2013

CEO Roundtable on Cancer recognizes UMB Financial with CEO Cancer Gold Standard

UMB Financial Corporation, a financial services holding company headquartered in Kansas City, MO, is leading by example when it comes to promoting workplace wellness and encouraging healthier behavior. The CEO Roundtable on Cancer recently accredited UMB Financial with the CEO Cancer Gold Standard.

17 Jun 2013

First Edition: June 17, 2013

Today's headlines include reports about how states are tackling the implementation of specific provisions of the health law.

17 Jun 2013

Final results of PUFs clinical study of Covidien's Pipeline device published in June issue of Radiology

Covidien, a leading global provider of healthcare products, today announced that the final results of the PUFs (Pipeline for Uncoilable or Failed Aneurysms) clinical study of its Pipeline embolization device have been published in the June issue of Radiology.

17 Jun 2013

Study: British South Asians more likely to be severely depressed following cancer diagnosis

The first study of its kind to investigate depression following cancer diagnosis among British white people and South Asians in the UK has discovered that South Asians are five times more likely to be severely depressed.

17 Jun 2013

Transition, Lilly amend agreement to address future development of TT-401

Transition Therapeutics Inc. announced that Eli Lilly and Company has exercised its option to assume all development and commercialization rights to type 2 diabetes drug candidate TT-401.

17 Jun 2013

Genmab, ADC Therapeutics agree to develop new antibody-drug conjugate product

Genmab A/S and ADC Therapeutics Sarl, announced today an agreement to develop a new antibody-drug conjugate product combining Genmab's HuMax-TAC antibody and ADC Therapeutics' PBD-based warhead and linker technology.

17 Jun 2013

NGM, MedImmune partner to develop novel therapeutics for treatment of diabetes and obesity

NGM Biopharmaceuticals, Inc. and MedImmune, the global biologics research and development arm of AstraZeneca, announced today that they have entered into an exclusive agreement to discover, develop and commercialize novel therapeutics from NGM's enteroendocrine cell program for the treatment of type 2 diabetes and obesity.

17 Jun 2013

Orexo announces dosing of first patient with Zubsolv in phase III clinical study

Orexo AB announces today that the first patient has been dosed with Zubsolv in a phase III study for a new clinical indication for Zubsolv.

17 Jun 2013

Athera receives support from FP7 for development of fully human antibody PC-mAb

Athera Biotechnologies AB today announced that future development costs of its fully human antibody PC-mAb up until proof-of-concept will be co-funded by the European Union's Seventh Framework Programme for Research (FP7) through a collaborative research grant. Karolinska Development AB owns 65% of Athera Biotechnologies AB.

17 Jun 2013

European Commission amends marketing authorisation for Celgene's REVLIMID

Celgene International Sàrl was today notified that the European Commission has amended the marketing authorisation for REVLIMID. This decision means that REVLIMID is now approved to treat patients with transfusion-dependent anaemia due to low or intermediate-1 risk myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality when other therapeutic options are insufficient or inadequate.

17 Jun 2013

Medical Condition News

Concerns raised about disproportionate impact of changes in hospital payment methods

New study identifies possible treatment to block deposition of calcium in arterial wall

HPV antibodies may help identify individuals at increased risk of HPV-related oropharynx cancer

Drug increases amount of energy burned by fat tissue and promotes weight loss

Increasing red meat intake boosts risk of type-2 diabetes mellitus

Study shows clear correlation between infection levels and risk of developing mood disorders

Mannitol could prevent aggregation of toxic proteins in the brain, says Tel Aviv University researcher

Studies show fewer mental health inpatients experience delayed discharge from hospital

Study: Male mice fed with high-fat diet are more likely to father offspring with higher levels of body fat

Bazedoxifene used for treating osteoporosis stops growth of breast cancer cells

CEO Roundtable on Cancer recognizes UMB Financial with CEO Cancer Gold Standard

First Edition: June 17, 2013

Final results of PUFs clinical study of Covidien's Pipeline device published in June issue of Radiology

Study: British South Asians more likely to be severely depressed following cancer diagnosis

Transition, Lilly amend agreement to address future development of TT-401

Genmab, ADC Therapeutics agree to develop new antibody-drug conjugate product

NGM, MedImmune partner to develop novel therapeutics for treatment of diabetes and obesity

Orexo announces dosing of first patient with Zubsolv in phase III clinical study

Athera receives support from FP7 for development of fully human antibody PC-mAb

European Commission amends marketing authorisation for Celgene's REVLIMID

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News